Freund John Gordon

Director at COLL; Director at SIBN; Director at STRO, and 4 more

Sold, on record
$110M
Dollars the filings state
Form 4 sales
32
Latest May 18, 2026
Form 144 notices
1
Proposed sales
Companies
7
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
2
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale SIBNPlan not stated
    Jun 16 2021

    Sold 52,092 shares at $31.24 ($1.6M)

    Freund John Gordon, Director

    Sold 13.6% of holdings ($12M position)331,366 shares left0.3x usual sizeFiling

  2. 2 Form 144 notice SIBNNotice
    Aug 9 +784 days

    Filed to sell 30,000 shares ($624k)

    Freund John Gordon, Director

    No 10b5-1 planFirst sale on recordFiling

  3. 3 Form 4 sale SIBNNo plan
    Aug 9 same day

    Sold 30,000 shares at $20.54 ($616k)

    Freund John Gordon, Director

    No 10b5-1 planSold 22.4% of holdings ($2.8M position)103,899 shares leftFirst sale on recordFollows a Form 144Filing

  4. 4 Form 4 sale COLLNo plan
    Jun 9 +670 days

    Sold 6,601 shares at $30.62 ($202k)

    Freund John Gordon, Director

    No 10b5-1 planSold 8.5% of holdings ($2.4M position)70,658 shares leftFirst sale on recordFiling

  5. 5 Form 4 sale SIBNNo plan
    Aug 8 +60 days

    Sold 12,132 shares at $15.99 ($194k)

    Freund John Gordon, Director

    No 10b5-1 planSold 11.7% of holdings ($1.7M position)91,767 shares leftFiling

  6. 6 Form 4 sale COLLUnusual
    Aug 8 same day

    Sold 11,659 shares at $34.36 ($401k)

    Freund John Gordon, Director

    No 10b5-1 planSold 33.5% of holdings ($1.2M position)23,129 shares leftFiling

  7. 7 Form 4 sale COLLNo plan
    May 15 +280 days

    Sold 4,127 shares at $34.54 ($143k)

    Freund John Gordon, Director

    No 10b5-1 planSold 4.7% of holdings ($3M position)83,972 shares leftFiling

  8. 8 Form 4 sale COLLNo plan
    May 18 +3 days

    Sold 20 shares at $34.05 ($681)

    Freund John Gordon, Director

    No 10b5-1 planSold 0% of holdings ($2.9M position)83,952 shares left0x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (33)

Form 144 notices and Form 4 sales by Freund John Gordon
Source
May 18, 2026COLLDirectorForm 4 sale20$6810.0%No planSEC
May 15, 2026COLLDirectorForm 4 sale4,127$143k4.7%No planSEC
Aug 8, 2025COLLDirectorForm 4 sale11,659$401k33.5%UnusualSEC
Aug 8, 2025SIBNDirectorForm 4 sale12,132$194k11.7%No planSEC
Jun 9, 2025COLLDirectorForm 4 sale6,601$202k8.5%No planSEC
Aug 9, 2023SIBNDirectorForm 4 sale30,000$616k22.4%No planSEC
Aug 9, 2023SIBNDirectorForm 144 notice30,000$624kNoticeSEC
Jun 16, 2021SIBNDirectorForm 4 sale52,092$1.6M13.6%Plan not statedSEC
May 28, 2021SIBNDirectorForm 4 sale71,587$2.2M15.7%Plan not statedSEC
May 26, 2021SIBNDirectorForm 4 sale69,861$2.3M13.3%Plan not statedSEC
Mar 17, 2021SIBNDirectorForm 4 sale721,253$21.9M57.9%UnusualSEC
Mar 15, 2021SIBNDirectorForm 4 sale235,887$7.3M15.9%Plan not statedSEC
Dec 3, 2020SIBNDirectorForm 4 sale147,886$3.4M9.1%Plan not statedSEC
Oct 19, 2020SIBNDirector, 10% ownerForm 4 sale190,053$4.2M8.2%Plan not statedSEC
Sep 18, 2020STRODirectorForm 4 sale400,000$4.8M41.7%UnusualSEC
Sep 11, 2020STRODirectorForm 4 sale500,000$5M34.2%UnusualSEC
Aug 19, 2020STRODirectorForm 4 sale500,000$4.4M25.5%UnusualSEC
Jan 27, 2020SIBNDirector, 10% ownerForm 4 sale1M$21.5M26.2%UnusualSEC
Dec 10, 2019TETRAPHASE PHARMACEUTICALS INCDirectorForm 4 sale15,031$33k100.0%UnusualSEC
Aug 26, 2019SIBNDirector, 10% ownerForm 4 sale152,424$2.8M3.8%Plan not statedSEC
Aug 23, 2019SIBNDirector, 10% ownerForm 4 sale47,576$959k1.2%Plan not statedSEC
Aug 12, 2019SIBNDirector, 10% ownerForm 4 sale400,000$7.3M9.0%Plan not statedSEC
Nov 11, 2015XENOPORT INCDirectorForm 4 sale909$6k0.2%Plan not statedSEC
Feb 20, 2015Dicerna Pharmaceuticals IncOtherForm 4 sale37,532$977k2.1%Plan not statedSEC
Oct 27, 2014TARADirector, 10% ownerForm 4 sale56,038$560k3.8%Plan not statedSEC
Oct 2, 2014TETRAPHASE PHARMACEUTICALS INCDirectorForm 4 sale247,734$5.2M21.8%Plan not statedSEC
Sep 30, 2014TETRAPHASE PHARMACEUTICALS INCDirectorForm 4 sale152,266$3.1M11.8%Plan not statedSEC
Sep 17, 2014TETRAPHASE PHARMACEUTICALS INCDirectorForm 4 sale144,356$2.5M10.1%Plan not statedSEC
Sep 12, 2014TETRAPHASE PHARMACEUTICALS INCDirectorForm 4 sale55,644$946k3.7%Plan not statedSEC
Sep 8, 2014TETRAPHASE PHARMACEUTICALS INCDirectorForm 4 sale16,700$251k1.1%Plan not statedSEC
Sep 4, 2014TETRAPHASE PHARMACEUTICALS INCDirectorForm 4 sale183,300$2.8M10.8%Plan not statedSEC
Jun 23, 2014TETRAPHASE PHARMACEUTICALS INCDirectorForm 4 sale47,184$650k2.7%Plan not statedSEC
Jun 20, 2014TETRAPHASE PHARMACEUTICALS INCDirectorForm 4 sale152,816$2M8.1%Plan not statedSEC